RxDoctor Payments Data

Christopher Gregorich, PA

Physician Assistant · Hummelstown, PANPI 1730284829

Payments from drug & device makers

$1,028in general payments, 2019–2025

Across 59 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$257
  • AstraZeneca$240
  • Pfizer$99
  • Lilly USA, LLC$88
  • AbbVie$86
  • E.r. Squibb & Sons, L.L.C.$51
  • plus $206 from 9 others

What the payments were for

  • Food & beverage$1,01499%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,028 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$40,232
Medicare patients
135
Services billed
603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$69,066
EliquisApixaban41$58,660
Tresiba Flextouch U-200Insulin Degludec33$40,585
RybelsusSemaglutide25$37,379
JardianceEmpagliflozin28$35,104
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr28$17,007
LinzessLinaclotide13$6,796
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$5,785
Atorvastatin Calcium417$4,541
Tolterodine Tartrate ErTolterodine Tartrate14$3,035
Rosuvastatin Calcium232$2,800
Metoprolol Succinate132$2,188
Metformin Hcl ErMetformin Hcl126$2,039
Pantoprazole Sodium164$1,789
Colesevelam Hcl12$1,710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$257$106,44585 claims
PfizerEliquis$99$58,66041 claims
Boehringer IngelheimJardiance, Stiolto Respimat$34$40,88941 claims
AbbVieLinzess, Synthroid$86$7,72032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Hummelstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →